Diverse Resistant Mechanisms Identified Using Serial Next-Generation Sequencing in a Patient With ALK-Rearranged Metastatic Lung Adenocarcinoma: A Case Report
Both tissue and plasma-based next generation sequencing (NGS) facilitate the identification of actionable oncogene alterations at diagnosis and resistant mechanisms on progression. The value of longitudinal profiling is less established among patients with ALK-rearranged NSCLC, underpinned by concer...
Main Authors: | Stephanie Pei Li Saw, MRCP, Darren Wan-Teck Lim, MRCP |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-06-01
|
Series: | JTO Clinical and Research Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666364323000516 |
Similar Items
-
Multiple Genetic Alterations as Resistance Mechanism during Second-Line Lorlatinib for Advanced ALK-Rearranged Lung Adenocarcinoma: A Case Report
by: Annamaria Catino, et al.
Published: (2022-03-01) -
Remarkable response to alectinib for metastatic papillary thyroid cancer with STRN-ALK fusion: A case report
by: Lucheng Zhu, et al.
Published: (2022-11-01) -
Management of Oligoprogression in Patients with Metastatic NSCLC Harboring ALK Rearrangements
by: Chiara Pisano, et al.
Published: (2022-01-01) -
Case report: Concomitant EGFR mutation and ALK rearrangement in non-small cell lung cancer
by: Haoyue Hu, et al.
Published: (2023-08-01) -
Successful Treatment of ALK-Positive Large-Cell Neuroendocrine Carcinoma of the Lung With Sequential ALK Inhibitors: A Case Report
by: Takayuki Kobayashi, MD, et al.
Published: (2023-07-01)